OptimizeRx (NASDAQ:OPRX) Issues Quarterly Earnings Results, Misses Estimates By $0.16 EPS

OptimizeRx (NASDAQ:OPRXGet Free Report) released its quarterly earnings results on Tuesday. The company reported ($0.27) earnings per share for the quarter, missing the consensus estimate of ($0.11) by ($0.16), Zacks reports. The business had revenue of $19.69 million during the quarter, compared to analysts’ expectations of $18.66 million. OptimizeRx had a negative net margin of 24.56% and a negative return on equity of 7.72%. During the same period in the previous year, the business earned ($0.34) EPS.

OptimizeRx Stock Up 25.1 %

OptimizeRx stock traded up $2.63 during mid-day trading on Wednesday, hitting $13.11. The company had a trading volume of 408,667 shares, compared to its average volume of 129,354. The company has a current ratio of 3.04, a quick ratio of 3.04 and a debt-to-equity ratio of 0.27. The stock’s 50 day moving average price is $11.41 and its two-hundred day moving average price is $12.29. OptimizeRx has a 12 month low of $6.92 and a 12 month high of $16.65. The company has a market capitalization of $238.34 million, a PE ratio of -12.48 and a beta of 1.05.

Analysts Set New Price Targets

A number of equities analysts have commented on the stock. JMP Securities reissued a “market outperform” rating and issued a $15.00 price target on shares of OptimizeRx in a research note on Tuesday, April 16th. Royal Bank of Canada reiterated an “outperform” rating and set a $17.00 price objective on shares of OptimizeRx in a research report on Monday, April 1st. Finally, Stifel Nicolaus reissued a “buy” rating and set a $13.00 price objective on shares of OptimizeRx in a report on Wednesday. One research analyst has rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $15.86.

View Our Latest Stock Analysis on OptimizeRx

OptimizeRx Company Profile

(Get Free Report)

OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers (HCPs), and patients. Its products and applications include Evidence-Based Physician Engagement solution to assist HCPs in identifying patients who may be qualified for specific therapies, raise awareness of patient access pathways, and identify early indicators of non-adherence among patient populations; and Point of Care Banner messaging solution to deliver a variety of awareness and messaging within the clinical workflow.

Further Reading

Earnings History for OptimizeRx (NASDAQ:OPRX)

Receive News & Ratings for OptimizeRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OptimizeRx and related companies with MarketBeat.com's FREE daily email newsletter.